Published in J Clin Pathol on September 01, 1990
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients. J Clin Pathol (1993) 0.95
Age dependent hypergastrinaemia in children with Helicobacter pylori gastritis--evidence of early acquisition of infection. Gut (1995) 0.86
Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication. Biomed Res Int (2014) 0.84
Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics. Gastroenterol Res Pract (2011) 0.83
Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. Gut (1993) 0.80
Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR. PLoS One (2014) 0.75
Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Lancet (1989) 4.53
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology (1982) 3.05
Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet (1989) 2.14
Person-to-person transmission of Campylobacter pylori. Lancet (1987) 1.93
Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion (1987) 1.87
Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology (1975) 1.68
Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut (1989) 1.49
Acid secretion and serum gastrin levels in individuals with Campylobacter pylori. Gastroenterology (1988) 1.28
Use of endoscopy in patients with dyspepsia. BMJ (1989) 1.24
Campylobacter-like organisms and gastritis: histopathology, bile reflux, and gastric fluid composition. Scand J Gastroenterol (1987) 1.07
Serum group I pepsinogens in children. Acta Paediatr Scand (1980) 0.94
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36
Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med (1991) 4.60
Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science (1998) 4.24
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12
Expression cloning of a protective Leishmania antigen. Science (1995) 2.83
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76
IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol (1999) 2.69
Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med (1980) 2.50
Campylobacter pylori in abattoir workers: is it a zoonosis? Lancet (1988) 2.41
Urease tests for Campylobacter pylori: care in interpretation. J Clin Pathol (1988) 2.35
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet (1989) 2.14
Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics (1996) 2.14
Endoscopic biliary therapy using the combined percutaneous and endoscopic technique. Gastroenterology (1989) 1.99
Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96
Cusum plotting of temperature charts for assessing antimicrobial treatment in neutropenic patients. BMJ (1989) 1.95
The heritability and genetics of frontotemporal lobar degeneration. Neurology (2009) 1.86
Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology (1996) 1.83
Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology (1997) 1.83
Diagnosis of coeliac disease: time for a change? Arch Dis Child (1989) 1.76
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Aliment Pharmacol Ther (2005) 1.75
Duodenal ulcer, Helicobacter pylori, and gastric secretion. Gut (1994) 1.75
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol (1994) 1.69
Endoscopy in dyspeptic patients: is gastric mucosal biopsy useful? Am J Gastroenterol (1990) 1.60
Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58
Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer (2007) 1.57
High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther (2003) 1.57
Biliary stent blockage with bacterial biofilm. A light and electron microscopy study. Ann Intern Med (1988) 1.56
Four hour rapid urease test (RUT) for detecting Campylobacter pylori: is it reliable enough to start treatment? J Clin Pathol (1988) 1.53
Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut (1989) 1.49
Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol (1997) 1.47
Hypothalamo-hypophysial dysfunction after traumatic brain injury in children and adolescents: a preliminary retrospective and prospective study. J Pediatr Endocrinol Metab (2006) 1.47
Sputum induction for the diagnosis of pulmonary disease in HIV positive patients. J Infect (1991) 1.46
Anaplastic large cell lymphomas: a study of 75 pediatric patients. Pediatr Dev Pathol (2007) 1.46
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol (2003) 1.44
Langhans giant cells from M. tuberculosis-induced human granulomas cannot mediate mycobacterial uptake. J Pathol (2007) 1.44
Identification of Corynebacterium jeikeium and Corynebacterium CDC group D2 with the API 20 Strep system. Eur J Clin Microbiol Infect Dis (1988) 1.41
Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer. Can J Anaesth (1994) 1.41
Family treatment of symptomatic children with Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1997) 1.41
Crusted ("Norwegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med (1996) 1.40
Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci (1991) 1.40
Aluminum and dialysis arthropathy. Nephron (1990) 1.39
Two HLA-D and DR alleles are associated with coeliac disease. Tissue Antigens (1979) 1.34
Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev (2000) 1.28
Antibody titres to Campylobacter pylori after treatment for gastritis. BMJ (1988) 1.27
Bacterial flora on the white coats of medical students. J Hosp Infect (2000) 1.26
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest (2000) 1.24
Use of endoscopy in patients with dyspepsia. BMJ (1989) 1.24
Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA. HIV Med (2011) 1.23
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J Clin Pathol (2008) 1.22
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. Neuromuscul Disord (2010) 1.21
A report of a further hospital outbreak caused by a multi-resistant Acinetobacter anitratus. J Hosp Infect (1982) 1.20
Review article:invasive and non-invasive tests for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.19
Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods (1995) 1.19
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Aliment Pharmacol Ther (2005) 1.18
Does breast feeding protect against the development of clinical symptoms of celiac disease in children? J Pediatr Gastroenterol Nutr (1983) 1.16
Characterization of conditions required for X-Ray diffraction experiments with protein microcrystals. Biophys J (2000) 1.16
Diagnosis of Helicobacter pylori infection by HpSA test. European Helicobacter pylori HpSA Study Group. Lancet (1999) 1.16
Infections in IFNGR-1-deficient children. J Interferon Cytokine Res (1997) 1.16
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res (1983) 1.16
PCR primers that can detect low levels of Mycobacterium leprae DNA. J Med Microbiol (2001) 1.15
Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family. J Clin Pathol (2006) 1.15
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance. Dig Liver Dis (2007) 1.15
An assessment of the long-term preservation of the DNA of a bacterial pathogen in ethanol-preserved archival material. J Pathol (2000) 1.15
Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology (2008) 1.14
A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child. Am J Hum Genet (1998) 1.12
Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut (1983) 1.12
Sclerosing cholangitis in acquired immunodeficiency syndrome. Case reports and review of the literature. Scand J Gastroenterol (1988) 1.12
Evaluation of microbicidal activity of a new disinfectant: Sterilox 2500 against Clostridium difficile spores, Helicobacter pylori, vancomycin resistant Enterococcus species, Candida albicans and several Mycobacterium species. J Hosp Infect (1999) 1.11
Return of splenic function after splenectomy: how much tissue is needed? Br Med J (Clin Res Ed) (1984) 1.11
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. Neurology (2003) 1.10
Genetic alterations of the BRI2 gene: familial British and Danish dementias. Brain Pathol (2006) 1.09
Searching for rehabilitation articles on MEDLINE and EMBASE. An example with cross-over design. Arch Phys Med Rehabil (2000) 1.09
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther (2007) 1.09
Needle knife papillotomy: how safe and how effective? Gut (1990) 1.08
Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid. J Clin Microbiol (2001) 1.08
The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut (1998) 1.08
Carbon monoxide pretreatment prevents respiratory derangement and ameliorates hyperacute endotoxic shock in pigs. FASEB J (2005) 1.07
Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole. Gut (1992) 1.07
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J Immunol (1987) 1.07
Transmission of tuberculosis by patients with HIV infection. BMJ (1994) 1.07